1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. NEKTAR THERAPEUTICS

Nektar Therapeutics

XNAS: NKTR

Momentum Trap
Download real time

0.69 NA (NA%)

60.57% Fall from 52W High

1.6M XNAS Volume

XNAS 20 May, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
8S
15W
0O
3T
128.4

Market Cap

Below industry Median
-1

PE TTM

Negative PE TTM
0

PEG TTM

2.1

Price to Book

Below industry Median
-0.3

Beta 1Year

Very Low volatility
Board Meeting
The next board meeting for Nektar Therapeutics is on 23 May 2025 for the purpose of Nektar Therapeutics Annual General Meeting for 2025 See details

Nektar Therapeutics - NKTR - stock price prediction, stock price target, analyst ratings from 8 analysts

Nektar Therapeutics has a share price target of US$ 5, revenue growth forecast of -56.6%, and profit growth estimate of -51.6% for FY25, based on top 8 analyst calls.

Forecaster Screeners